Lotus Neuro
PrivateLast Round
Corporate Funding
Dec 17, 2025
Momentum Score
25 /100
Company Overview
Lotus Neuro is a clinical-stage biotechnology company that advances brain-targeted combination therapeutics using precision, low-frequency focused ultrasound.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lotus Neuro Comps
Public and private peers based on sector, stage, and business model.
Lotus Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 17, 2025 |
Lotus Neuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nexus NeuroTech Ventures | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Led by Nexus NeuroTech Ventures
Lotus Neuro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lotus Neuro's valuation, stock price, and market status.
